Analytics software and solutions developer SAS has developed a single platform to support companies to comply with data standardization activities for the Identification of Medicinal Products (IDMP).
The global regulatory standardization framework was developed in response to a worldwide demand for internationally consistent specifications for medicinal products and substances. In addition to IDMP compliance, the platform delivers a foundation to support other regulatory requirements. This includes the Falsified Medicines Directive and the General Data Protection Regulation.
It is expected that other regulatory agencies such as the US Food & Drug Administration and the Pharmaceuticals and Medical Devices Agency in Japan will also adopt these standards into regional legislation.
"SAS brings a deep understanding of regulations and industry experience to the development of an IDMP platform," said Mark Lambrecht, director of the Global Health and Life Sciences Practice at SAS. "All regulatory agencies will have different timelines, and this offering will help our customers comply with data standardization and product safety regulations globally.”
